Trial of Vitamin D in HIV Progression, Birth Outcomes, and Child Health

PHASE3CompletedINTERVENTIONAL
Enrollment

2,300

Participants

Timeline

Start Date

June 15, 2015

Primary Completion Date

September 18, 2019

Study Completion Date

September 18, 2019

Conditions
HIV
Interventions
DIETARY_SUPPLEMENT

Vitamin D3 (cholecalciferol)

Supplements containing 3,000 IU vitamin D3 taken orally once per day by the mother starting from the second trimester until 12 months postpartum

OTHER

Placebo

Placebo supplements taken orally once per day by the mother starting from the second trimester until 12 months postpartum

Trial Locations (1)

Unknown

Management and Development for Health (MDH), Dar es Salaam

All Listed Sponsors
collaborator

Management and Development for Health (MDH)

UNKNOWN

lead

Wafaie Fawzi

OTHER

NCT02305927 - Trial of Vitamin D in HIV Progression, Birth Outcomes, and Child Health | Biotech Hunter | Biotech Hunter